Deregulation of RGS2 in cardiovascular diseases

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 2, 2010, Pages 547-557

  Tsang, Sharon ^a   Woo, Anthony Yiu Ho ^a   Zhu, Weizhong ^a   Xiao, Rui Ping ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Cardiovascular system; GPCR signaling; Regulator of G protein signaling; Review

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; RGS PROTEIN; RGS2 PROTEIN, HUMAN;

ANIMAL; CARDIOMEGALY; CARDIOVASCULAR DISEASE; GENE EXPRESSION REGULATION; HEART MUSCLE; HUMAN; HYPERTENSION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOMEGALY; CARDIOVASCULAR DISEASES; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; HYPERTENSION; MICE; MYOCARDIUM; RGS PROTEINS; SIGNAL TRANSDUCTION;

EID: 77957293797     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. D. Levy, M. G. Larson, R. S. Vasan, W. B. Kannel and K. K. Ho: The progression from hypertension to congestive heart failure. Jama, 275 (20), 1557-1562 (1996) (Pubitemid 26154241)
2. W. B. Kannel, D. Levy and L. A. Cupples: Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J Cardiovasc Pharmacol, 10 Suppl 6, S135-40 (1987)
3. G. L. Jennings: Noradrenaline spillover and microneurography measurements in patients with primary hypertension. J Hypertens Suppl, 16 (3), S35-8 (1998) (Pubitemid 28433258)
4. C. Ferrier, M. D. Esler, G. Eisenhofer, B. G. Wallin, M. Horne, H. S. Cox, G. Lambert and G. L. Jennings: Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension, 19 (1), 62-9 (1992)
5. M. Esler, D. Kaye, G. Lambert, D. Esler and G. Jennings: Adrenergic nervous system in heart failure. Am J Cardiol, 80 (11A), 7L-14L (1997) (Pubitemid 27528443)
6. M. R. Bristow: Mechanisms of Development of Heart Failure in the Hypertensive Patient. Cardiology, 92 (Suppl. 1), 3-6 (1999)
7. D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou and A. D. Eckhart: Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension. Am J Physiol Heart Circ Physiol, 293 (5), H3072-3079 (2007) (Pubitemid 350106532)
8. V. LaMorte, J. Thorburn, D. Absher, A. Spiegel, J. Brown, K. Chien, J. Feramisco and K. Knowlton: Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J. Biol. Chem., 269 (18), 13490-13496 (1994)
9. S. A. Akhter, L. M. Luttrell, H. A. Rockman, G. Iaccarino, R. J. Lefkowitz and W. J. Koch: Targeting the Receptor-Gq Interface to Inhibit in vivo Pressure Overload Myocardial Hypertrophy. Science, 280 (5363), 574-577 (1998) (Pubitemid 28227758)
10. N. Wettschureck, H. Rutten, A. Zywietz, D. Gehring, T. M. Wilkie, J. Chen, K. R. Chien and S. Offermanns: Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat Med, 7 (11), 1236-40 (2001) (Pubitemid 33063779)
11. D. D. D' Angelo, Y. Sakata, J. N. Lorenz, G. P. Boivin, R. A. Walsh, S. B. Liggett and G. W. Dorn: Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA, 94 (15), 8121-8126 (1997) (Pubitemid 27343787)
12. T. Eschenhagen, U. Mende, M. Nose, W. Schmitz, H. Scholz, A. Haverich, S. Hirt, V. Doring, P. Kalmar, W. Hoppner: Increased messenger RNA level of the inhibitory G protein alpha subunit Gi alpha-2 in human end-stage heart failure. Circ Res, 70 (4), 688-96 (1992)
13. D. S. Feldman, T. S. Elton, B. Sun, M. M. Martin and M. T. Ziolo: Mechanisms of Disease: detrimental adrenergic signaling in acute decompensated heart failure. Nat Clin Pract Cardiovasc Med, 5 (4), 208-218 (2008) (Pubitemid 351472165)
14. O. E. Brodde: Beta-adrenoceptors in cardiac disease. Pharmacol Ther, 60 (3), 405-430 (1993)
15. A. M. Feldman, A. E. Cates, W. B. Veazey, R. E. Hershberger, M. R. Bristow, K. L. Baughman, W. A. Baumgartner and C. Van Dop: Increase of the 40, 000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest, 82 (1), 189-97 (1988) (Pubitemid 18262515)
16. M. C. Hendriks-Balk, S. L. M. Peters, M. C. Michel and A. E. Alewijnse: Regulation of G protein-coupled receptor signalling: Focus on the cardiovascular system and regulator of G protein signalling proteins. Eur J Pharmacol, 585 (2-3), 278-291 (2008)
17. S. Salim, S. Sinnarajah, J. H. Kehrl and C. W. Dessauer: Identification of RGS2 and Type V Adenylyl Cyclase Interaction Sites. J. Biol. Chem., 278 (18), 15842-15849 (2003) (Pubitemid 36799699)
18. P. Vantrimpont, J. L. Rouleau, C. C. Wun, A. Ciampi, M. Klein, B. Sussex, J. M. Arnold, L. Moye and M. Pfeffer: Additive Beneficial Effects of Beta-Blockers to Angiotensin-Converting Enzyme Inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. J Am Coll Cardiol, 29 (2), 229-236 (1997) (Pubitemid 27059948)
19. J. Frank: Managing hypertension using combination therapy. Am Fam Physician, 77 (9), 1279-86 (2008)
20. C. Rosendorff: Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement. J Clin Hypertens (Greenwich), 9 (10), 790-5 (2007)
21. S. Erdine, O. Ari, A. Zanchetti, R. Cifkova, R. Fagard, S. Kjeldsen, G. Mancia, N. Poulter, K. H. Rahn, J. L. Rodicio, L. M. Ruilope, J. Staessen, P. van Zwieten, B. Waeber and B. Williams: ESH-ESC guidelines for the management of hypertension. Herz, 31 (4), 331-8 (2006) (Pubitemid 44046496)
22. K. Wachtell, B. Dahlof, J. Rokkedal, V. Papademetriou, M. S. Nieminen, G. Smith, E. Gerdts, K. Boman, J. N. Bella and R. B. Devereux: Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Am Heart J, 144 (6), 1057-1064 (2002) (Pubitemid 36026920)
23. M. Hartford, I. Wendelhag, G. Berglund, I. Wallentin, S. Ljungman and J. Wikstrand: Cardiovascular and renal effects of long-term antihypertensive treatment. Jama, 259 (17), 2553-7 (1988)
24. F. G. Dunn, H. O. Ventura, F. H. Messerli, I. Kobrin and E. D. Frohlich: Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol. Circulation, 76 (2), 254-8 (1987) (Pubitemid 17127004)
25. M. Shahi, S. Thom, N. Poulter, P. S. Sever and R. A. Foale: Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic function. The Lancet, 336 (8713), 458-461 (1990) (Pubitemid 20264214)
26. F. G. Dunn, W. Oigman, H. O. Ventura, F. H. Messerli, I. Kobrin and E. D. Frohlich: Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol, 53 (1), 105-108 (1984) (Pubitemid 14217516)
27. E. J. Eichhorn, C. M. Heesch, J. H. Barnett, L. G. Alvarez, S. M. Fass, P. A. Grayburn, B. A. Hatfield, L. G. Marcoux and C. R. Malloy: Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol, 24 (5), 1310-20 (1994) (Pubitemid 24331872)
28. R. Adorisio, L. De Luca, J. Rossi and M. Gheorghiade: Pharmacological treatment of chronic heart failure. Heart Failure Reviews, 11 (2), 109-123 (2006) (Pubitemid 44288726)
29. A. D. Lopez and C. D. Mathers: Measuring the global burden of disease and epidemiological transitions: 20022030. Ann Trop Med Parasitol, 100, 481-499 (2006) (Pubitemid 47050869)
30. A. D. Lopez, C. D. Mathers, M. Ezzati, D. T. Jamison and C. J. L. Murray: Global and regional burden of disease and risk factors: systematic analysis of population health data. Lancet, 367 (9524), 1747-1757 (2001)
31. L. D. Adams, R. L. Geary, B. McManus and S. M. Schwartz: A Comparison of Aorta and Vena Cava Medial Message Expression by cDNA Array Analysis Identifies a Set of 68 Consistently Differentially Expressed Genes, All in Aortic Media. Circ Res, 87 (7), 623-631 (2000)
32. C. Mittmann, C. H. Chung, G. Hoppner, C. Michalek, M. Nose, C. Schuler, A. Schuh, T. Eschenhagen, J. Weil, B. Pieske, S. Hirt and T. Wieland: Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc Res, 55 (4), 778-786 (2002)
33. H. Cho, K. Harrison, O. Schwartz and J. H. Kehrl: The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. Biochem. J., 371 (3), 973-980 (2003) (Pubitemid 36578896)
34. J. Hao, C. Michalek, W. Zhang, M. Zhu, X. Xu and U. Mende: Regulation of cardiomyocyte signaling by RGS proteins: Differential selectivity towards G proteins and susceptibility to regulation. Journal of Molecular and Cellular Cardiology, 41 (1), 51-61 (2006) (Pubitemid 44172945)
35. S. Zhang, N. Watson, J. Zahner, J. N. Rottman, K. J. Blumer and A. J. Muslin: RGS3 and RGS4 are GTPase Activating Proteins in the Heart. J Mol Cell Cardiol, 30 (2), 269-276 (1998) (Pubitemid 28116306)
36. S. P. Heximer, S. P. Srinivasa, L. S. Bernstein, J. L. Bernard, M. E. Linder, J. R. Hepler and K. J. Blumer: G Protein Selectivity Is a Determinant of RGS2 Function. J. Biol. Chem., 274 (48), 34253-34259 (1999) (Pubitemid 129511765)
37. S. P. Heximer, N. Watson, M. E. Linder, K. J. Blumer and J. R. Hepler: RGS2/G0S8 is a selective inhibitor of Gqα function. Proc Natl Acad Sci USA, 94 (26), 14389-14393 (1997)
38. A. Semplicini, L. Lenzini, M. Sartori, I. Papparella, L. A. Calo, E. Pagnin, G. Strapazzon, C. Benna, R. Costa, A. Avogaro, G. Ceolotto and A. C. Pessina: Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens, 24 (6), 1115-24 (2006) (Pubitemid 43772320)
39. J. Yang, K. Kamide, Y. Kokubo, S. Takiuchi, C. Tanaka, M. Banno, Y. Miwa, M. Yoshii, T. Horio, A. Okayama, H. Tomoike, Y. Kawano and T. Miyata: Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens, 23 (8), 1497-505 (2005) (Pubitemid 41104821)
40. L. A. Calo, E. Pagnin, P. A. Davis, M. Sartori, G. Ceolotto, A. C. Pessina and A. Semplicini: Increased Expression of Regulator of G Protein Signaling-2 (RGS-2) in Bartter's/Gitelman's Syndrome. A Role in the Control of Vascular Tone and Implication for Hypertension. J Clin Endocrinol Metab, 89 (8), 4153-4157 (2004) (Pubitemid 39071528)
41. S. P. Heximer, R. H. Knutsen, X. Sun, K. M. Kaltenbronn, M. H. Rhee, N. Peng, A. Oliveira-dos-Santos, J. M. Penninger, A. J. Muslin, T. H. Steinberg, J. M. Wyss, R. P. Mecham and K. J. Blumer: Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest, 111 (4), 445-52 (2003) (Pubitemid 36228001)
42. K. M. Tang, G. R. Wang, P. Lu, R. H. Karas, M. Aronovitz, S. P. Heximer, K. M. Kaltenbronn, K. J. Blumer, D. P. Siderovski, Y. Zhu and M. E. Mendelsohn: Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med, 9 (12), 1506-12 (2003) (Pubitemid 38004778)
43. E. Takimoto, N. Koitabashi, S. Hsu, E. A. Ketner, M. Zhang, T. Nagayama, D. Bedja, K. L. Gabrielson, R. Blanton, D. P. Siderovski, M. E. Mendelsohn and D. A. Kass: Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest, 119 (2), 408-20 (2009)
44. W. Zhang, T. Anger, J. Su, J. Hao, X. Xu, M. Zhu, A. Gach, L. Cui, R. Liao and U. Mende: Selective Loss of Fine Tuning of Gq/11 Signaling by RGS2 Protein Exacerbates Cardiomyocyte Hypertrophy. J. Biol. Chem., 281 (9), 5811-5820 (2006) (Pubitemid 43853012)
45. M. X. Zou, A. A. Roy, Q. Zhao, L. A. Kirshenbaum, M. Karmazyn and P. Chidiac: RGS2 is upregulated by and attenuates the hypertrophic effect of [alpha]1-adrenergic activation in cultured ventricular myocytes. Cell Signal, 18 (10), 1655-1663 (2006)
46. W. B. Kannel: Incidence and Epidemiology of Heart Failure. Heart Fail Rev, 5 (2), 167-173 (2000)
47. S. L. Grant, B. Lassegue, K. K. Griendling, M. Ushio-Fukai, P. R. Lyons and R. W. Alexander: Specific Regulation of RGS2 Messenger RNA by Angiotensin II in Cultured Vascular Smooth Muscle Cells. Mol Pharmacol, 57 (3), 460-467 (2000) (Pubitemid 30140875)
48. E. L. Riddle, B. K. Rana, K. K. Murthy, F. Rao, E. Eskin, D. T. O'Connor and P. A. Insel: Polymorphisms and Haplotypes of the Regulator of G Protein Signaling-2 Gene in Normotensives and Hypertensives. Hypertension, 47 (3), 415-420 (2006) (Pubitemid 43740284)
49. M. Lelonek, T. Pietrucha, M. Matyjaszczyk and J. H. Goch: Polymorphism C1114G of Gene Encoding the Cardiac Regulator of G-Protein Signaling 2 May Be Associated with Number of Episodes of Neurally Mediated Syncope. Archives of Medical Research, 40 (3), 191-195 (2009)
50. X. Sun, K. M. Kaltenbronn, T. H. Steinberg and K. J. Blumer: RGS2 Is a Mediator of Nitric Oxide Action on Blood Pressure and Vasoconstrictor Signaling. Mol Pharmacol, 67 (3), 631-639 (2005) (Pubitemid 40365310)
51. L. A. Calo, E. Pagnin, G. Ceolotto, P. A. Davis, S. Schiavo, I. Papparella, A. Semplicini and A. C. Pessina: Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes. J Hypertens, 26 (5), 938-45 (2008) (Pubitemid 351520981)
52. A. Wirth, Z. Benyo, M. Lukasova, B. Leutgeb, N. Wettschureck, S. Gorbey, P. Orsy, B. Horvath, C. Maser-Gluth, E. Greiner, B. Lemmer, G. Schutz, S. Gutkind and S. Offermanns: G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med, 14 (1), 64-68 (2008)
53. W. Grossman, D. Jones and L. P. McLaurin: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest, 56 (1), 56-64 (1975)
54. A. Diwan and G. W. Dorn, II: Decompensation of Cardiac Hypertrophy: Cellular Mechanisms and Novel Therapeutic Targets. Physiology, 22 (1), 56-64 (2007)
55. F. H. Messerli and T. Grodzicki: Hypertension, left ventricular hypertrophy, ventricular arrhythmias and sudden death. Eur Heart J, 13, 66-9 (1992)
56. B. H. Lorell: Transition from hypertrophy to failure. Circulation, 96 (11), 3824-7 (1997) (Pubitemid 27506035)
57. U. Mende, A. Kagen, A. Cohen, J. Aramburu, F. J. Schoen and E. J. Neer: Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad of Sci USA, 95 (23), 13893-13898 (1998)
58. J. R. Keys, E. A. Greene, W. J. Koch and A. D. Eckhart: Gq-Coupled Receptor Agonists Mediate Cardiac Hypertrophy Via the Vasculature. Hypertension, 40 (5), 660-666 (2002) (Pubitemid 35278602)
59. G. Esposito, A. Rapacciuolo, S. V. Naga Prasad and H. A. Rockman: Cardiac hypertrophy: Role of G protein-coupled receptors. J Card Fail, 8 (6, Part 2), S409-S414 (2002) (Pubitemid 36083092)
60. G. W. Dorn II, H. S. Hahn: Genetic Factors in Cardiac Hypertrophy. Ann N Y Acad Sci, 1015, 225-237 (2004) (Pubitemid 38879493)
61. C. Hague, L. S. Bernstein, S. Ramineni, Z. Chen, K. P. Minneman and J. R. Hepler: Selective Inhibition of {alpha}1A-Adrenergic Receptor Signaling by RGS2 Association with the Receptor Third Intracellular Loop. J. Biol. Chem., 280 (29), 27289-27295 (2005) (Pubitemid 41040769)
62. J. D. Molkentin, J.R. Lu, C. L. Antos, B. Markham, J. Richardson, J. Robbins, S. R. Grant and E. N. Olson: A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy. Cell, 93 (2), 215-228 (1998) (Pubitemid 28180855)
63. P. Tamirisa, K. J. Blumer and A. J. Muslin: RGS4 Inhibits G-Protein Signaling in Cardiomyocytes. Circulation, 99 (3), 441-447 (1999) (Pubitemid 29051272)
64. J. H. Rogers, A. Tsirka, A. Kovacs, K. J. Blumer, G. W. Dorn and A. J. Muslin: RGS4 Reduces Contractile Dysfunction and Hypertrophic Gene Induction in Gαq Over-expressing Mice. J Mol Cell Cardiol, 33 (2), 209-218 (2001) (Pubitemid 32537921)
65. T. Tokudome, I. Kishimoto, T. Horio, Y. Arai, D. O. Schwenke, J. Hino, I. Okano, Y. Kawano, M. Kohno, M. Miyazato, K. Nakao and K. Kangawa: Regulator of G-Protein Signaling Subtype 4 Mediates Antihypertrophic Effect of Locally Secreted Natriuretic Peptides in the Heart. Circulation, 117 (18), 2329-2339 (2008) (Pubitemid 351653552)
66. K. Tojo, S. Sato, G. Tokudome, M. Ohta, Y. Kawaguchi, O. Sakai, O. Nakagawa and K. Nakao: Stimulation by Corticotropin-Releasing Factor of Atrial Natriuretic Peptide and Brain Natriuretic Peptide Secretions from Cultured Neonatal Rat Cardiomyocytes. Biochem Biophys Res Commun, 225 (2), 340-346 (1996) (Pubitemid 26355605)
67. J. H. Rogers, P. Tamirisa, A. Kovacs, C. Weinheimer, M. Courtois, K. J. Blumer, D. P. Kelly and A. J. Muslin: RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J Clin Invest, 104 (5), 567-76 (1999)
68. W. B. Kannel, W. P. Castelli, P. M. McNamara, P. A. McKee and M. Feinleib: Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med, 287 (16), 781-7 (1972)
69. G. Esposito, A. Rapacciuolo, S. V. Naga Prasad, H. Takaoka, S. A. Thomas, W. J. Koch and H. A. Rockman: Genetic Alterations That Inhibit in vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress. Circulation, 105 (1), 85-92 (2002) (Pubitemid 34049147)
70. S. V. Prasad, J. Nienaber and H. A. Rockman: G-protein-coupled receptor function in heart failure. Cold Spring Harb Symp Quant Biol, 67, 439-44 (2002) (Pubitemid 36775539)
71. R. P. Xiao, S. J. Zhang, K. Chakir, P. Avdonin, W. Z. Zhu, R. A. Bond, C. W. Balke, E. G. Lakatta and H. P. Cheng: Enhanced Gi signaling selectively negates β2-adrenergic receptor (AR)- but not β1-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation, 108 (13), 1633-1639 (2003) (Pubitemid 37187792)
72. A. A. Roy, A. Baragli, L. S. Bernstein, J. R. Hepler, T. E. Hebert and P. Chidiac: RGS2 interacts with Gs and adenylyl cyclase in living cells. Cell Signal, 18 (3), 336-348 (2006) (Pubitemid 41661349)
73. V. J. Owen, P. B. J. Burton, A. J. Mullen, E. J. Birks, P. Barton and M. H. Yacoub: Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. Eur Heart J, 22 (12), 1015-1020 (2001) (Pubitemid 32737563)
74. Y. Takeishi, T. Jalili, B. D. Hoit, D. L. Kirkpatrick, L. E. Wagoner, W. T. Abraham and R. A. Walsh: Alterations in Ca2+ cycling proteins and G?q signaling after left ventricular assist device support in failing human hearts. Cardiovasc Res, 45 (4), 883-888 (2000) (Pubitemid 30089650)
75. Y. Li, S. Hashim and M. B. Anand-Srivastava: Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells. Cardiovasc Res, 66 (3), 503-511 (2005) (Pubitemid 40725762)
76. P. A. Insel and R. S. Ostrom: Forskolin as a Tool for Examining Adenylyl Cyclase Expression, Regulation, and G Protein Signaling. Cell Mol Neurobiol, 23, 305-314 (2003) (Pubitemid 36676277)
77. D. J. Pepperl, S. Shah-Basu, D. VanLeeuwen, J. G. Granneman and R. G. MacKenzie: Regulation of RGS mRNAs by cAMP in PC12 Cells. Biochem Biophys Res Commun, 243 (1), 52-55 (1998) (Pubitemid 28414188)
78. P. Osei-Owusu, X. Sun, R. M. Drenan, T. H. Steinberg and K. J. Blumer: Regulation of RGS2 and Second Messenger Signaling in Vascular Smooth Muscle Cells by cGMP-dependent Protein Kinase. J. Biol. Chem., 282 (43), 31656-31665 (2007) (Pubitemid 350044901)
79. L. Kalinowski, I. T. Dobrucki and T. Malinski: Race-Specific Differences in Endothelial Function: Predisposition of African Americans to Vascular Diseases. Circulation, 109 (21), 2511-2517 (2004) (Pubitemid 38720549)
80. T. Munzel, S. Genth-Zotz and U. Hink: Targeting Heme-Oxidized Soluble Guanylate Cyclase: Solution for All Cardiorenal Problems in Heart Failure? Hypertension, 49 (5), 974-976 (2007) (Pubitemid 351664319)
81. T. Malinski: Understanding Nitric Oxide Physiology in the Heart: A Nanomedical Approach. Am J Cardiol, 96 (7, Supplement 2), 13-24 (2005)
82. M. Dupuis, F. Soubrier, I. Brocheriou, S. Raoux, M. Haloui, L. Louedec, J.-B. Michel and S. Nadaud: Profiling of Aortic Smooth Muscle Cell Gene Expression in Response to Chronic Inhibition of Nitric Oxide Synthase in Rats. Circulation, 110 (7), 867-873 (2004) (Pubitemid 39096016)